Skip to content

Clinical trials

Enrolling by invitation Schizophrenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Enrolling by invitation Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20212
20221
20233
20244
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Butler Hospital2
Tianjin Anding Hospital2
Alkermes, Inc.1
Bezmialem Vakif University1
Douglas Mental Health University Institute1
Eli Lilly and Company1
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1
Istanbul Arel University1
Medical University of Lodz1
Rene Kahn1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia17
Bipolar Disorder5
Psychotic Disorders5
Major Depressive Disorder4
Mental Disorders2
Alzheimer Disease1
Cognitive Dysfunction1
Language Disorders1
Neurodegenerative Diseases1
Obsessive-Compulsive Disorder1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.